Europe Real Time Polymerase Chain Reaction Market: Market Size & Forecast 2026

Real-time PCR, also known as quantitative PCR (qPCR), constitutes the largest segment within Europe's PCR technologies market, which encompasses real-time, digital, and end-point PCR systems. The European molecular diagnostics market, valued at $5.6 billion in 2025, relies heavily on PCR technology which holds a dominant 38% market share. Real-time PCR instruments have emerged as the primary driver of adoption, serving critical roles in clinical diagnostics, pharmaceutical research, and food safety testing across the region.

• •Europe represents approximately 27% of global PCR testing market activity
• •Real-time PCR is the largest segment within quantitative PCR technologies
• •PCR technology holds 38% share of the European molecular diagnostics market

The infectious disease diagnostics segment, heavily reliant on PCR technology, is projected to grow from $293.2 million in 2025 to $439.1 million by 2030 at an 8.4% CAGR, significantly outpacing overall market growth. Point-of-care molecular diagnostics, where PCR-based technology leads as the primary segment, is valued at $1.52 billion in 2025 and expected to reach $2.17 billion by 2030 at a 7.5% CAGR. Government research funding programs and supportive regulatory frameworks across European Union member states continue to facilitate market expansion and innovation.

• •Infectious disease diagnostics driven by PCR growing at 8.4% CAGR through 2030
• •Point-of-care molecular diagnostics expanding at 7.5% CAGR with PCR as leading technology
• •Government research funding and regulatory frameworks supporting market development

The European PCR market demonstrates varied growth patterns across Western Europe, where established healthcare infrastructure supports higher adoption rates, and Eastern Europe, where emerging markets show accelerating demand. Real-time PCR dominates the quantitative segment, while digital PCR represents an emerging segment with growing clinical research applications. The infectious disease diagnostics application segment shows the strongest growth trajectory compared to other PCR applications in the region.

• •Western Europe leads in adoption due to established healthcare infrastructure and laboratory networks
• •Real-time PCR dominates quantitative PCR segment with instrument-driven adoption
• •Infectious disease diagnostics represents the fastest-growing application segment at 8.4% CAGR

What are the recent trends and outlook?

The European PCR market is positioned for steady growth through 2030, supported by increasing emphasis on rapid diagnostic testing and personalized medicine initiatives across the region. Integration of PCR technologies with artificial intelligence and automation platforms is expected to enhance workflow efficiency and expand clinical utility in hospital and research settings. Point-of-care PCR applications and digital PCR innovations will likely drive the next phase of market evolution, though the overall market faces moderate growth compared to adjacent molecular diagnostics segments.

• •Point-of-care PCR and digital PCR technologies expected to drive future innovation and market expansion
• •Integration with AI and automation platforms enhancing clinical workflow efficiency and data analysis
• •Market projected to maintain steady growth trajectory aligned with long-term regional demand